Joint hypermobility linked to longer COVID-19 recovery time

FHS
March 20, 2024
11:16 pm

Study shows that individuals with generalized joint hypermobility have a 30% higher risk of not recovering from acute COVID-19, highlighting the need for tailored treatment and care.

Recursion nears ‘moment of truth’ with first key data, kicking off 18-month flurry of readouts

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 30, 2024

CytoReason secures $80m investment for AI expansion

The funding will aid CytoReason to expand disease models and proprietary data. Credit: PeopleImages.com – Yuri A / Shutterstock. CytoReason has secured $80m in funding

July 18, 2024

Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process | Psychedelic Invest

Newcourt Acquisition Corp (“Newcourt”) (NASDAQ: NCAC) announced today that the conditions to closing the business combination (the “Business Combination”) pursuant to the Amended and Restated Business

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.